6uap
From Proteopedia
(Difference between revisions)
m (Protected "6uap" [edit=sysop:move=sysop]) |
|||
Line 1: | Line 1: | ||
- | '''Unreleased structure''' | ||
- | + | ==Crystal structure of tryptophan synthase from M. tuberculosis - open form with BRD6309 bound== | |
- | + | <StructureSection load='6uap' size='340' side='right'caption='[[6uap]], [[Resolution|resolution]] 2.75Å' scene=''> | |
- | + | == Structural highlights == | |
- | + | <table><tr><td colspan='2'>[[6uap]] is a 8 chain structure. This structure supersedes the now removed PDB entry [http://oca.weizmann.ac.il/oca-bin/send-pdb?obs=1&id=6du1 6du1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6UAP OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6UAP FirstGlance]. <br> | |
- | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=ACT:ACETATE+ION'>ACT</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=FMT:FORMIC+ACID'>FMT</scene>, <scene name='pdbligand=H9V:(2R,3S,4R)-3-(4-chloro-2,6-difluoro[1,1-biphenyl]-4-yl)-4-(fluoromethyl)azetidine-2-carbonitrile'>H9V</scene>, <scene name='pdbligand=MLA:MALONIC+ACID'>MLA</scene>, <scene name='pdbligand=MLT:D-MALATE'>MLT</scene></td></tr> | |
- | [[Category: | + | <tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=LLP:(2S)-2-AMINO-6-[[3-HYDROXY-2-METHYL-5-(PHOSPHONOOXYMETHYL)PYRIDIN-4-YL]METHYLIDENEAMINO]HEXANOIC+ACID'>LLP</scene></td></tr> |
+ | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Tryptophan_synthase Tryptophan synthase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=4.2.1.20 4.2.1.20] </span></td></tr> | ||
+ | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6uap FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6uap OCA], [http://pdbe.org/6uap PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6uap RCSB], [http://www.ebi.ac.uk/pdbsum/6uap PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6uap ProSAT]</span></td></tr> | ||
+ | </table> | ||
+ | == Function == | ||
+ | [[http://www.uniprot.org/uniprot/TRPA_MYCTU TRPA_MYCTU]] The alpha subunit is responsible for the aldol cleavage of indoleglycerol phosphate to indole and glyceraldehyde 3-phosphate. [[http://www.uniprot.org/uniprot/TRPB_MYCTU TRPB_MYCTU]] The beta subunit is responsible for the synthesis of L-tryptophan from indole and L-serine (By similarity). | ||
+ | __TOC__ | ||
+ | </StructureSection> | ||
+ | [[Category: Large Structures]] | ||
+ | [[Category: Tryptophan synthase]] | ||
+ | [[Category: Structural genomic]] | ||
+ | [[Category: Chang, C]] | ||
+ | [[Category: Jedrzejczak, R]] | ||
+ | [[Category: Joachimiak, A]] | ||
+ | [[Category: Maltseva, N I]] | ||
+ | [[Category: McCarren, P]] | ||
[[Category: Michalska, K]] | [[Category: Michalska, K]] | ||
- | [[Category: | + | [[Category: Nag, P P]] |
- | + | ||
- | + | ||
[[Category: Satchell, K]] | [[Category: Satchell, K]] | ||
- | [[Category: | + | [[Category: Allostery]] |
- | [[Category: | + | [[Category: Amino acid biosynthesis]] |
- | [[Category: | + | [[Category: Csgid]] |
- | [[Category: | + | [[Category: Heterotetramer]] |
+ | [[Category: Lyase-lyase inhibitor complex]] | ||
+ | [[Category: Plp]] | ||
+ | [[Category: Substrate channeling]] |
Revision as of 08:57, 30 October 2019
Crystal structure of tryptophan synthase from M. tuberculosis - open form with BRD6309 bound
|
Categories: Large Structures | Tryptophan synthase | Structural genomic | Chang, C | Jedrzejczak, R | Joachimiak, A | Maltseva, N I | McCarren, P | Michalska, K | Nag, P P | Satchell, K | Allostery | Amino acid biosynthesis | Csgid | Heterotetramer | Lyase-lyase inhibitor complex | Plp | Substrate channeling